Safety, immunogenicity, and efficacy of Borrelia burgdorferi outer surface protein A (OspA) vaccine: A meta-analysis

Safety, immunogenicity, and efficacy of Borrelia burgdorferi outer surface protein A (OspA) vaccine: A meta-analysis

Introduction: Lyme borreliosis, caused by Borrelia burgdorferi sensu stricto in the United States and by several Borrelia species in Europe and Asia, has a great impact on the health of the global population. There are human vaccines available, such as the outer surface protein A (OspA) vaccine, but...

Full description

Saved in:
Bibliographic Details
Main Authors: Hua Zhao, Fukai Frank Bao, Aihua Liu
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2017-01-01
Series:Journal of Infection in Developing Countries
Subjects:
vaccine
Lyme disease
OspA
safety
immunogenicity
efficacy
Online Access:https://jidc.org/index.php/journal/article/view/7999
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items